Federal Pharmacy Law Exam Practice 2026 – Complete Study Resource

The purpose of the therapeutic equivalence information found in the Orange Book is to guide pharmacists in selecting interchangeable medications. The Orange Book, officially known as the Approved Drug Products with Therapeutic Equivalence Evaluations, assists healthcare professionals by identifying which drug products can be considered therapeutically equivalent to one another. This ensures that when a generic or alternative formulation is selected, it will provide the same clinical benefit as the brand-name drug.

Therapeutic equivalence is assessed based on the drug's active ingredient, dosage form, strength, and route of administration. The information is vital for pharmacists as it helps them make informed decisions when recommending or dispensing medications, ensuring that patients receive effective treatment options that are safe and of comparable quality to the brand-name products. This resource is instrumental in promoting the use of generics, which can provide cost savings while maintaining the therapeutic effectiveness of the treatment.

The other choices do not reflect the primary purpose of the Orange Book. Economic comparisons are not within its scope, nor does the book assess patient completion rates or track drug recalls, which are outside the focus of its therapeutic equivalence evaluations.